Search details
1.
Germline genetic factors influence the outcome of interferon-α therapy in polycythemia vera.
Blood
; 137(3): 387-391, 2021 01 21.
Article
in English
| MEDLINE | ID: mdl-32814349
2.
Phenotypic characterization of disease-initiating stem cells in JAK2- or CALR-mutated myeloproliferative neoplasms.
Am J Hematol
; 98(5): 770-783, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36814396
3.
PD-L1 overexpression correlates with JAK2-V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasms.
Am J Hematol
; 97(4): 390-400, 2022 04.
Article
in English
| MEDLINE | ID: mdl-35015307
4.
Mutational landscape of the transcriptome offers putative targets for immunotherapy of myeloproliferative neoplasms.
Blood
; 134(2): 199-210, 2019 07 11.
Article
in English
| MEDLINE | ID: mdl-31064751
5.
CDK6 coordinates JAK2 V617F mutant MPN via NF-κB and apoptotic networks.
Blood
; 133(15): 1677-1690, 2019 04 11.
Article
in English
| MEDLINE | ID: mdl-30635286
6.
Clonal Hematopoiesis with Oncogenic Potential (CHOP): Separation from CHIP and Roads to AML.
Int J Mol Sci
; 20(3)2019 Feb 12.
Article
in English
| MEDLINE | ID: mdl-30759825
7.
Cooperation of germ line JAK2 mutations E846D and R1063H in hereditary erythrocytosis with megakaryocytic atypia.
Blood
; 128(10): 1418-23, 2016 09 08.
Article
in English
| MEDLINE | ID: mdl-27389715
8.
Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms.
Blood
; 127(3): 325-32, 2016 Jan 21.
Article
in English
| MEDLINE | ID: mdl-26423830
9.
8p11 myeloproliferative syndrome: diagnostic challenges and pitfalls.
J BUON
; 21(3): 745-9, 2016.
Article
in English
| MEDLINE | ID: mdl-27569099
10.
Germline RBBP6 mutations in familial myeloproliferative neoplasms.
Blood
; 127(3): 362-5, 2016 Jan 21.
Article
in English
| MEDLINE | ID: mdl-26574608
Results
1 -
10
de 10
1
Next >
>>